SynthesisJournal of robotic surgery2026
A probabilistic multicriteria decision analysis of robot-assisted versus laparoscopic sacrocolpopexy: a secondary analysis of published meta-analytic data.
Synthesis in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Given that the overall comparative advantage between robot-assisted sacrocolpopexy (RASC) and laparoscopic sacrocolpopexy (LSC) remains unclear, a secondary analysis using multicriteria decision analysis (MCDA) was conducted to explore their overall differences across multiple outcomes. Methods: A secondary quantitative analysis was performed using pooled effect estimates from the meta-analysis by Chang et al. Ten outcomes were evaluated, such as the operative time, blood loss, perioperative complications, and anatomical measures. Each pooled estimate and its 95% confidence interval were approximated by a normal probability distribution under standard meta-analytic assumptions. Monte Carlo sampling was employed to generate estimated probabilities that RASC outperformed LSC. Outcomes were categorized into resource, safety, and efficacy domains. Four MCDA scenarios were examined: equal weighting and scenarios emphasizing resource, safety, or efficacy. Composite MCDA scores and the probability that RASC was preferred overall (Pr[RASC preferred]) were calculated for each scenario. Robustness was evaluated using weight-perturbation sensitivity analysis. Results: At the individual outcome level, RASC demonstrated a very high estimated probability of reducing blood loss and intraoperative complications, whereas LSC was highly likely to provide a shorter operative time. In MCDA, RASC was consistently favored across all weighting scenarios, with the Pr(RASC preferred) value ranging from 0.86 to 0.95 and expected MCDA scores from 0.66 to 0.76. Sensitivity analysis demonstrated only minor fluctuations in MCDA outputs, supporting robustness. Conclusions: When multiple outcomes were considered simultaneously, the overall profiles of RASC and LSC demonstrated differences across clinically plausible weighting structures.
Indexed as
Identifiers
41840315What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.